# 2026-00792: FDA Reviews Plans for Rotating Tobacco Health Warnings

2026-00792, Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Warning Plans for Certain Tobacco Products, is a Federal Register notice from Health and Human Services Department, Food and Drug Administration published 2026-01-16, effective Submit written comments (including recommendations) on the collection of information by February 17, 2026. (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2026-00792
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-00792
- Title: Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Warning Plans for Certain Tobacco Products
- Type: Notice
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 91 FR 2135
- Published: 2026-01-16
- Effective: Submit written comments (including recommendations) on the collection of information by February 17, 2026.
- Comments close: 2026-02-17
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

FDA Reviews Plans for Rotating Tobacco Health Warnings

## Summary

The FDA is asking for public feedback on a plan that tobacco companies must submit to show how they’ll randomly display health warnings on certain tobacco products. This helps make sure warnings are clear and fair, protecting people from tobacco risks. Comments are open until February 17, 2026, and this process keeps the rules up to date without extra costs for businesses.

## Abstract

The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-20848](https://policyrisk.com/federal-register/2026-20848): Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods, 2026-10-13
- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27

## Sources
- [2026-00792 on federalregister.gov](https://www.federalregister.gov/documents/2026/01/16/2026-00792/agency-information-collection-activities-submission-for-office-of-management-and-budget-review)
- [2026-00792 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-01-16/pdf/2026-00792.pdf)

## Related
- [Previous: 2026-00791, Agency Information Collection Activities; Proposed Collection; Comment Request;…](https://policyrisk.com/federal-register/2026-00791)
- [Next: 2026-00793, Agency Information Collection Activities; Proposed Collection; Comment Request;…](https://policyrisk.com/federal-register/2026-00793)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-00792 (as of 2026-06-08).
